I can explain the shorting as a naive way of following the trend, exactly like new investors jumping in to buy the uptrend. In both cases, it's a mistake and certain events that are unexpected can burn both sides. The company is financially and fundamentally sound, the cash burn rate will decrease dramatically and revenue will increase from zohydro sales that's one of a kind in the 8.6 billions market place. I'll allow some time for management to re strategies and find the right direction imo